IRWD
Ironwood Pharmaceuticals Inc
NASDAQ: IRWD · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$4.15
-1.19% today
Updated 2026-04-29
Market cap
$658.76M
P/E ratio
26.93
P/S ratio
2.22x
EPS (TTM)
$0.15
Dividend yield
—
52W range
$1 – $6
Volume
2.8M
WallStSmart proprietary scores
44
out of 100
Grade: D
Sell
Investment rating
4.7
Growth
C5.0
Quality
C+6.0
Profitability
B7.0
Valuation
B+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →204 stocks currently score above 75
Price targets
Analyst target
$6.10
+46.99%
12-Month target
$3.94
-5.06%
Intrinsic (DCF)
$28.51
Margin of safety
+84.43%
1 Strong Buy1 Buy2 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
+ Free cash flow $74.57M — positive
+ 84.43% below intrinsic value
Risks
- Revenue declining -47.30% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $410.60M | $442.74M | $351.41M | $296.15M | $296.15M |
| Net income | $175.06M | $-1.00B | $880000.00 | $24.02M | $-2.28M |
| EPS | — | — | — | — | $0.15 |
| Free cash flow | $273.63M | $183.15M | $103.41M | $127.01M | $74.57M |
| Profit margin | 42.64% | -226.37% | 0.25% | 8.11% | 8.11% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-03-17 | DENNER, ALEXANDER J | Sale | 6,725,000 | $3.05 |
| 2026-03-17 | DENNER, ALEXANDER J | Sale | 5,800 | $3.31 |
| 2026-03-13 | DENNER, ALEXANDER J | Buy | 4,451 | — |
Peer comparison
Smart narrative
Ironwood Pharmaceuticals Inc trades at $4.15. representing a P/E of 26.93x trailing earnings. Our Smart Value Score of 44/100 indicates the stock is fair. TTM revenue stands at $296.15M. with profit margins at 8.11%. Our DCF model estimates intrinsic value at $28.51.
Frequently asked questions
What is Ironwood Pharmaceuticals Inc's stock price?
Ironwood Pharmaceuticals Inc (IRWD) trades at $4.15.
Is Ironwood Pharmaceuticals Inc overvalued?
Smart Value Score 44/100 (Grade D, Sell). DCF value $28.51.
What is the price target of Ironwood Pharmaceuticals Inc (IRWD)?
The analyst target price is $6.10, representing +47.0% upside from the current price of $4.15.
What is the intrinsic value of Ironwood Pharmaceuticals Inc (IRWD)?
Based on our DCF model, intrinsic value is $28.51, a +84.4% margin of safety versus $4.15.
What is the future stock price of IRWD by 2030?
Our revenue-driven model estimates Ironwood Pharmaceuticals Inc could reach $2.48 by 2030, based on historical CAGR, margin trends, and capped P/E multiples.
What is Ironwood Pharmaceuticals Inc's revenue?
TTM revenue is $296.15M.
Company info
SectorHEALTHCARE
IndustryDRUG MANUFACTURERS - SPECIALTY & GENERIC
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio2.22x
ROE-575.00%
Beta0.17
50D MA$3.71
200D MA$2.74
Shares out0.16B
Float0.13B
Short ratio—
Avg volume2.8M
Performance
1 week+5.60%
1 month+6.41%
3 months-15.13%
YTD+23.15%
1 year—
3 years—
5 years—